Baylis Medical partners with Medtronic on innovative spinal tumor ablation technology


Date:13 January 2016
For immediate release


(Montreal, Canada, January 13, 2016)

Baylis Medical Company announces a partnership with Medtronic (NYSE: MDT) to enhance patient access to a highly innovative spinal tumour ablation system which recently received U.S. Food and Drug Administration (FDA) 510(k) clearance.

For physicians who treat patients with painful spine metastases, the OsteoCool™ RF Ablation System is the only cooled radiofrequency (RF) ablation technology that offers simultaneous, dual-probe capabilities – providing procedural flexibility and predictable, customized treatment.  Cooled RF ablation uses targeted high-frequency energy to ablate tumors.

Medtronic acquired the OsteoCool technology and associated intellectual property from Baylis Medical on December 16, 2015 and partnered with the company to further innovate the System.  Terms of the acquisition were not disclosed.

"The OsteoCool System expands our Pain Therapies portfolio," said Julie Foster, general manager and vice president of the Pain Therapies business in the Neuromodulation division, which is part of the Restorative Therapies Group at Medtronic.  "Our customers treat patients with Kyphon® Balloon Kyphoplasty who also have painful spinal metastases.  The OsteoCool system gives physicians a way to treat that pain in a single procedure with a familiar, minimally invasive technique."

"We're pleased to be partnering with Medtronic to improve the treatment of patients suffering from spinal metastases," said Kris Shah, president of Baylis Medical.  "Our company has a long, established track record of developing innovative clinical solutions.  We are excited that this partnership with Medtronic will enhance patient access to our novel spinal tumor ablation technology."

About Medtronic
Medtronic plc (, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 85,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

About Baylis Medical Company
Baylis Medical develops and markets high-technology medical devices used in the fields of interventional cardiology, interventional radiology, and spinal procedures. Our vision is to develop and market innovative medical therapies while Improving the Lives of People Around the World. The company has offices in Montreal and Toronto (Canada), Boston (USA), and London (U.K.). For more information, visit

Media Contact Person:
Luc Desaulniers,
Communications Associate,
Baylis Medical Company
Tel: 514-488-9801